Synergistic activation of the CMV promoter by NF-kappaB P50 and PKG

Biochemical and Biophysical Research Communications
Bin He, G F Weber

Abstract

Several DNA binding NF-kappaB subunits are substrates for cGMP-dependent kinase (PKG) and their transactivation from cognate sites is induced by phosphorylation. This includes p50, which does not have a transcriptional activation domain and therefore needs to bind to other proteins to mediate gene expression. Here, we describe the synergistic transactivation by p50 and PKG from the CMV promoter. This is caused not only by phosphorylation of p50, leading to increased DNA binding, but also by PKG-dependent activation of CRE sites in the promoter. One of the CRE sites is located directly adjacent to a NF-kappaB site and is essential for p50-mediated induction of transcription. According to the binding of CREB to p50 in pull-down assays and according to the inhibition of p50-dependent transactivation by dominant-negative CREB, this reflects the formation of a transcription factor complex containing CREB and p50. The nuclear translocation of NF-kappaB is insufficient to distinguish among the multitude of promoters that harbor cognate recognition sites. The phosphorylation of multiple transcription factors by an upstream kinase, such as PKG, can lead to the formation of transcription factor complexes and differential transactivation ...Continue Reading

References

Mar 25, 1991·Nucleic Acids Research·O Bakker, M G Parker
Jan 1, 1990·The Journal of General Virology·T StammingerB Fleckenstein
Aug 1, 1996·Trends in Genetics : TIG·L A Stargell, K Struhl
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·M A MontanoG P Nolan
Jan 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·Y S ChangJ M Tarbell
Jun 26, 2002·The Journal of Biological Chemistry·Darren E CasteelRenate B Pilz

❮ Previous
Next ❯

Citations

Jul 17, 2008·Nucleic Acids Research·Christina Saeten FjeldboTorunn Bruland
Dec 27, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·James P MaloneyJames E Loyd
Jun 5, 2008·Cancer Letters·Georg F Weber
Dec 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Laura MeloniRudi Beyaert

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.